Aratana Therapeutics Inks $15M

Aratana Therapeutics, a company developing medicines for companion animals, has closed on $15 million in Series B financing. The company, since its launch earlier this year, has raised a total of $31 million. Existing shareholders MPM Capital, Avalon Ventures and Cultivian Ventures contributed to the round, as did new investor the Ewing Marion Kauffman Foundation. The company is based in Kansas City, Kansas.

North AmericaUSBriefs